• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mini-strokes can be ‘ominous prelude’ to catastrophic strokes

Bioengineer by Bioengineer
February 11, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Each year, more than 200,000 Americans experience mini-strokes called transient ischemic attacks (TIAs). Patients suffer stroke-like symptoms such as paralysis on one side or difficulty speaking. While symptoms typically go away in less than a few minutes and there’s no brain damage, TIAs often are followed by severe strokes.

TIAs are an “ominous prelude” to an impending cerebrovascular catastrophe, but also the opportunity to prevent a disabling event,” Loyola Medicine neurologists Camilo R. Gomez, MD, Michael J. Schneck, MD and José Biller, MD report in the journal F1000 Research. However, the neurologists add that rapid evaluation and treatment can reduce the risk of stroke by about 80 percent during the dangerous first week following a TIA.

Most strokes are ischemic, meaning they are caused by blood clots that block blood flow to a part of the brain. TIAs also are caused by blood clots, but the clots quickly dissolve or are dislodged. However, there’s a 5 to 10 percent risk of suffering a stroke during the 30 days following a TIA, and 15 to 20 percent of ischemic stroke patients report having experienced an earlier TIA.

A TIA requires urgent management, but there is controversy about how to accomplish this: Should patients be temporarily hospitalized, which may be safer, or should they be evaluated on an outpatient basis, which may be more convenient and cost effective? The existing literature is inconclusive. “Both approaches have advantages and disadvantages,” the Loyola neurologists wrote.

Traditionally, TIA patients have been admitted for a 23-hour observation period after they come to the emergency department. A recent alternative is to refer patients to a “TIA clinic”, where they are quickly seen by a stroke neurologist, undergo diagnostic tests and have access to a multidisciplinary network of cardiologists, neurosurgeons, vascular surgeons and other relevant specialists.

Therapeutic strategies include antiplatelet therapy (aspirin and other drugs that stop blood cells called platelets from sticking together and forming a clot); Coumadin and other blood thinners; surgery or stent placement to open clogged arteries; therapy to control blood pressure and cholesterol; diabetes screening; and patient education.

“Patients must be counselled about smoking cessation, proper diet (preferably Mediterranean), regular exercise, maintenance of appropriate BMI (body mass index) and limiting alcohol consumption,” Drs. Gomez, Schneck and Biller wrote.

The Loyola neurologists, who all specialize in stroke care, concluded: “The diagnosis of a TIA represents the recognition of a medical emergency and an opportunity to reduce the risk of stroke by decisively evaluating the patient and applying any combination of the currently available therapeutic strategies. The future is likely to show additional methods of early diagnosis, better algorithms for stroke risk stratification and enhanced systems of care for these patients.”

###

Drs. Gomez and Schneck are professors and Dr. Biller is professor and chair of Loyola Medicine’s department of neurology. Their paper is titled, “Recent advances in the management of transient ischemic attacks.”

Loyola’s Stroke Center offers a nationally recognized team of experts in every facet of stroke-related care, including emergency medicine, neurology, neurosurgery, neurophysiology, neuroradiology, rehabilitative services, social work, pharmacy and specialty nursing. For nine years in a row, Loyola University Medical Center has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award.

Media Contact

Jim Ritter
[email protected]
708-216-2445
@LoyolaHealth

http://www.luhs.org

http://dx.doi.org/10.12688/f1000research.12358.1

Share12Tweet8Share2ShareShareShare2

Related Posts

Personalized Guide to Understanding and Reducing Chemicals

February 7, 2026

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

February 7, 2026

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Personalized Guide to Understanding and Reducing Chemicals

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.